Osteomalacia clinical trials
The registry lists 34 studies for Osteomalacia across more than 10 countries. 3 are recruiting or about to start. 9 of them are mainly about Osteomalacia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.
Get an email when these change. Save the Osteomalacia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Alexion Pharmaceuticals, Inc. (13) · National Institute of Dental and Craniofacial Research (NIDCR) (4) · Kyowa Kirin Co., Ltd. (2) · Universitaire Ziekenhuizen KU Leuven (1) · University of Toronto (1) · University Hospital, Strasbourg, France (1) · I.M. Sechenov First Moscow State Medical University (1) · TUĞBA ŞAHBAZ (1)
What is being tested here
Drugs under test in Osteomalacia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
Of the 3 Osteomalacia studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (67%) | 2 (67%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 34 studies, recruiting or not: 44% stop at 75 or younger and 38% at 65; 59% take children; 6% are for women only and 3% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 34 of 34. search them.
- Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean PatientsRecruitingNCT062020271 country
- A Natural History Study of Bone and Mineral DisordersRecruitingNCT000248041 country
- Calcium-phosphate Complications Induced by IV Iron Supplementation in Patients With Rendu-Osler DiseaseRecruitingNCT055446691 country
- Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous DysplasiaCompletedNCT05509595Phase 21 country
- Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced OsteomalaciaCompletedNCT03736564Phase 1/21 country
- Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)WithdrawnNCT00894075Phase 2
- Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced OsteomalaciaStatus unknownNCT040458341 country
- Serum Prolidase Activity and the Role of Leptin in OsteomalaciaStatus unknownNCT05716750Not applicable
- Studies of States With Resistance to Vitamin D and Parathyroid HormoneCompletedNCT000012421 country
- Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman SpectroscopyActive, not recruitingNCT02814591
- A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT03233126Phase 31 country
- Dental Implants Rehabilitation in Patients With Vitamin D3 ImbalanceCompletedNCT04841213Not applicable1 country
- Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium DisordersCompletedNCT022526792 countries
- COMPREHENSIVE® REVERSE SHOULDER Mini BasePlateCompletedNCT020846931 country
- Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)CompletedNCT021042198 countries
- Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)CompletedNCT00952484Phase 22 countries
- Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)CompletedNCT00744042Phase 1/24 countries
- A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)CompletedNCT014190287 countries
- Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)CompletedNCT00739505Phase 12 countries
- Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)Approved for marketingNCT024966892 countries
- Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)CompletedNCT01203826Phase 22 countries
- Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09CompletedNCT022354931 country
- Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)CompletedNCT01205152Phase 23 countries
- Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)CompletedNCT01163149Phase 22 countries
- Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)CompletedNCT01176266Phase 2/312 countries
- Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)TerminatedNCT01748812Phase 11 country
- Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic OsteomalaciaCompletedNCT000997621 country
- Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in JapanCompletedNCT02531867Phase 4
- A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT02181764Phase 12 countries
- Maternal and Infant Vitamin Status During the First Nine Months of Infant LifeCompletedNCT025485201 country
- Serum Sclerostin Level & Treatment of Vitamin D DeficiencyCompletedNCT015533441 country
- Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral DensityCompletedNCT01025128Phase 41 country
- Serum FGF-23 and Vitamin D DeficiencyCompletedNCT011027511 country
- Nursing-Home Residents Given Bread Fortified With Vitamin D3CompletedNCT00789503Phase 1/2